通过多氨酸,L-Citrulline通过多氨酸改善了在孕前中IGF-1信号通路
Andy W C Man1, Joscha Steetskamp2, Josche van der Ven2
1Department of Pharmacology (A.W.C.M., G.R., N.X., H.L.), Cardiology I, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Hypertension (Dallas, Tex. : 1979)
|June 2, 2025
概括
补充L-氨酸可以通过增强胰岛素样生长因子1 (IGF-1) 信号传递来治疗孕前,部分是通过聚胺的产生. 这为这种严重的妊娠并发症提供了潜在的治疗策略.
科学领域:
- 产科和妇科 产科和妇科
- 分子医学是分子医学.
- 营养科学 营养科学
背景情况:
- 孕前是一种严重的妊娠并发症,缺乏有效的药理疗法.
- 以前的研究表明,L-氨酸可以改善大鼠模型中的孕前症.
- 这项研究研究了L-氨酸对L-氨酸作用的分子机制.
研究的目的:
- 阐明通过L-氨酸补充剂影响子宫前的分子机制.
- 研究IGF-1信号传递和多胺代谢在孕前中的作用.
- 为了探索L-素作为一种潜在的治疗药物用于孕前.
主要方法:
- 用L-citrulline治疗怀孕的达尔盐敏感老鼠.
- 招募孕前患者进行胎盘和血清样本采集.
- 对胎盘基因表达 (IGF-1,ZEB1,miR-486-5p,miR-210) 和血清聚胺水平的分析.
主要成果:
- 孕前胎盘显示IGF-1,ZEB1降低,并增加了miR-486-5p,miR-210.
- 在老鼠中,L-氨酸治疗使这些胎盘标记正常化,并维持血清聚胺水平.
- 氨酸和多氨酸在培养细胞中改善了IGF-1表达,其效果部分取决于IGF-1.
结论:
- 补充L-氨酸可以改善妊娠前的IGF-1信号,部分是通过聚胺的产生.
- 孕产妇补充L-素或聚胺可能是预防产前的安全有效的治疗策略.
相关概念视频
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Glucagon-like Receptor Agonists
438
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
438
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
260
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
260


